Cite
HARVARD Citation
Agarwal, N. et al. (2019). Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study. Lancet oncology. 20 (11), pp. 1518-1530. [Online].